These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3328469)

  • 21. [Effects of passive semiorthostatic cardiopulmonary hematic centralization (by immersion in water) on hydrosaline elimination and on the renin-angiotensin-aldosterone system in essential hypertension].
    Novarini A; Coruzzi P; Bruschi G; Ravanetti C; Musiari L; Biggi A; Borghetti A
    G Ital Cardiol; 1982; 12(10):695-701. PubMed ID: 7182207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of sympathetic and plasma renin activity on hemodialysis hypertension.
    Grekas D; Kalevrosoglou I; Karamouzis M; Geropoulou E; Kabouris H; Tourkantonis A
    Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Felodipine, a new vasodilating drug: blood pressure, cardiac, renal, and humoral effects in hypertensive patients.
    Leonetti G; Gradnik R; Terzoli L; Fruscio M; Rupoli L; Zanchetti A
    J Cardiovasc Pharmacol; 1984; 6(3):392-8. PubMed ID: 6202963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium antagonists in the treatment of hypertension: a critical overview.
    Weidmann P; Gerber A; Laederach K
    Adv Nephrol Necker Hosp; 1985; 14():197-232. PubMed ID: 3919532
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus.
    Nomura S; Inami N; Kimura Y; Omoto S; Shouzu A; Nishikawa M; Iwasaka T
    J Hum Hypertens; 2007 Jan; 21(1):38-44. PubMed ID: 17051237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of an adrenal inhibitor in hypertensive patients with suppressed renin.
    Woods JW; Liddle GW; Michelakis AM; Brill AB
    Arch Intern Med; 1969 Apr; 123(4):366-70. PubMed ID: 5778117
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of a beta-blocker on plasma renin activity of hypertensive patients.
    Salvetti A; Arzilli F; Baccini C
    J Nucl Biol Med; 1973; 17(3):142-50. PubMed ID: 4147719
    [No Abstract]   [Full Text] [Related]  

  • 28. Contrasting effects of nifedipine, captopril, and propranolol in normotensive and hypertensive subjects.
    MacGregor GA; Rotellar C; Markandu ND; Smith SJ; Sagnella GA
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S358-62. PubMed ID: 6184568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Functional dissociation of the kidney-adrenal axis in idiopathic hyperreninemic hypoaldosteronism].
    Morici ML
    Recenti Prog Med; 1987 Dec; 78(12):546-50. PubMed ID: 3330266
    [No Abstract]   [Full Text] [Related]  

  • 30. Antihypertensive effect of a new calcium channel blocker, FK 235, in essential hypertension.
    Mizuno K; Hashimoto S; Yabe R; Kunii N; Niimura S; Tani M; Watari H; Fukuchi S
    Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):3-15. PubMed ID: 3520729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of severe hypertension with nifedipine in combination with clonidine or propranolol.
    Imai Y; Abe K; Otsuka Y; Irokawa N; Yasujima M; Saito K; Sakurai Y; Chiba S; Ito T; Sato M; Haruyama T; Miura Y; Yoshinaga K
    Arzneimittelforschung; 1980; 30(4):674-8. PubMed ID: 6994751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of long-term treatment of arterial hypertension with Ca antagonists on the renin-angiotensin-aldosterone system in diabetics. Hyporeninemic hypoaldosteronism].
    Hrnciar J; Jakubíková K; Hrnciarová M; Kreze A; Chamulová M
    Vnitr Lek; 1995 Oct; 41(10):661-6. PubMed ID: 8578695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Variations of renin activity in hypertensive patients under aldactone therapy].
    Popov NG; Kiprov D; Astrug A; Dotschev D
    Med Welt; 1971 Jul; 22(29):1207-9. PubMed ID: 5566156
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hypertension and mineralocorticoids. Usefulness of renin and aldosterone measurements].
    Fardella CE; Montero J; Mosso L
    Rev Med Chil; 1999 May; 127(5):604-10. PubMed ID: 10451632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma catecholamines, renin and aldosterone during combined alpha- and beta- adrenoceptor blockade in patients with severe arterial hypertension.
    Kornerup HJ; Pedersen EB; Pedersen A; Pedersen G; Christensen NJ
    Postgrad Med J; 1980; 56 Suppl 2():49-52. PubMed ID: 7001422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Nifedipine in the treatment of essential hypertension].
    Condorelli M; Bonaduce D; Ferrara N; Petretta M; De Caprio L; Rengo F
    Rev Esp Cardiol; 1982; 35(5 Suppl 2):II7-12. PubMed ID: 6763269
    [No Abstract]   [Full Text] [Related]  

  • 38. [Longitudinal studies in essential hypertensive patients with low plasma renin activity].
    Esch I; Placheta P; Gaul G; Kneussel K
    Wien Klin Wochenschr; 1973 Sep; 85(38):617-21. PubMed ID: 4752255
    [No Abstract]   [Full Text] [Related]  

  • 39. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of guanabenz on plasma renin and aldosterone and on sodium balance in hypertensive patients].
    Bevilacqua M; Meroni R; Scorza D; Vago T; Norbiato G
    Minerva Cardioangiol; 1984 May; 32(5):267-71. PubMed ID: 6382053
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.